Use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) is associated with significantly increased rates of residual gastric…
Continue ReadingUse of glucagon-like peptide-1 receptor agonists (GLP-1RAs) is associated with significantly increased rates of residual gastric…
Continue Reading